Create a narrative

Xvivo Perfusion Community

OM:XVIVO Community

1 Narratives written by author
0 Comments on narratives written by author
14 Fair Values set on narratives written by author

Create a narrative

Xvivo Perfusion

AN

AnalystConsensusTarget

Consensus Narrative from 6 Analysts

DELIVER IDE Approvals And US Trials Will Unlock New Markets

Key Takeaways Regulatory approvals in the U.S. for liver and heart technologies and Canadian market expansions may significantly boost revenue and market share in North America. Strategic improvements in the Abdominal segment are set to increase gross margins and profitability, while strong adoption in Australia indicates promising growth.

SEK 448.50

FV

32.6% undervalued

31.15%

Revenue growth p.a.

0

0

9

6 days ago